
Glimeto MV 1mg/500mg/0.2mg Tablet
Manufacturer
Exito Pharma
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Key Information
Short Description
Glimeto MV 1mg/500mg/0.2mg Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Dosage Form
Tablet
Introduction
Glimeto MV 1mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes. Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Glimeto MV 1mg/500mg/0.2mg Tablet is to be taken empty stomach.
How it works
Glimeto MV 1mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines.
Quick Tips
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Related Medicines

Ozomet VG 1mg/500mg/0.2mg Tablet

Glimanthro-MV 1 Tablet

Afomet VG 1mg/500mg/0.2mg Tablet

Glucobit GM 1mg/500mg/0.2mg Tablet

Fineglim MV 1mg/500mg/0.2mg Tablet

Metasens VG 1mg Tablet

Glimgold MV 1mg Tablet

Glimitab-MV 1 Tablet

Glimestar MV 1mg/500mg/0.2mg Tablet

Volibose GM 1mg/500mg/0.2mg Tablet
Frequently asked questions
What is Glimeto MV 1mg/500mg/0.2mg Tablet?
Glimeto MV 1mg/500mg/0.2mg Tablet contains a combination of three active ingredients: Glimepiride, Metformin and Voglibose. This medication is prescribed for the treatment of type 2 diabetes mellitus (DM). It helps improve blood glucose levels in adults when used alongside a healthy diet and regular exercise.
What are the possible side effects of Glimeto MV 1mg/500mg/0.2mg Tablet?
Common side effects associated with Glimeto MV 1mg/500mg/0.2mg Tablet include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste perception, flatulence, stomach pain, headache, skin rash and respiratory tract infection.
Are there any specific conditions in which Glimeto MV 1mg/500mg/0.2mg Tablet should not be taken?
Before taking this medicine, consult a healthcare professional if you have known allergies to any of the ingredients or excipients. This medication is also contraindicated for patients with moderate to severe kidney disease and inflammatory bowel diseases, including colonic ulcerations, and individuals with underlying metabolic acidosis including diabetic ketoacidosis.
Is it safe to take alcohol while I am taking Glimeto MV 1mg/500mg/0.2mg Tablet?
No, alcohol should not be consumed while using this medication as it may lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Can the use of Glimeto MV 1mg/500mg/0.2mg Tablet cause hypoglycemia?
Yes, Glimeto MV 1mg/500mg/0.2mg Tablet can cause hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. It is more likely to occur if you skip meals, drink alcohol, engage in excessive exercise, or take other antidiabetic medications simultaneously. Regular monitoring of your blood sugar levels is essential.
What are the instructions for the storage and disposal of Glimeto MV 1mg/500mg/0.2mg Tablet?
Keep this medication in its original container, tightly sealed. Store it according to the instructions provided on the package or label. Dispose of unused medicine responsibly and ensure that pets, children, and other individuals do not have access to it.